What is Dawn?
Dawn operates at the intersection of behavioral health and digital therapeutics, focusing on the development of a scalable standard of care for insomnia. By leveraging technology to provide accessible, life-changing results, the company aims to mitigate the rising costs associated with chronic sleep disorders. Its platform is designed to empower individuals to take control of their sleep health, effectively bridging the gap between clinical intervention and daily wellness management. As a key player in the health tech landscape, Dawn is actively working to reduce the systemic healthcare burden through targeted, data-driven treatment protocols.
How much funding has Dawn raised?
Dawn has raised a total of $1.8M across 1 funding round:
Other Financing Round
$1.8M
Other Financing Round (2022): $1.8M with participation from OnDeck’s Runway Fund, Bragiel Brothers, and Kindred Ventures
Key Investors in Dawn
OnDeck’s Runway Fund
An investment vehicle associated with the OnDeck ecosystem, providing strategic capital to high-growth startups.
Bragiel Brothers
Bragiel Brothers offers a classic arcade gaming experience, focusing on retro gaming products and services. Their offerings cater to gaming enthusiasts who appreciate nostalgic gaming experiences.
Kindred Ventures
A venture capital firm that partners with founders to build transformative companies, leveraging deep expertise in early-stage growth and technology innovation.
What's next for Dawn?
Looking ahead, Dawn is poised to leverage its recent capital injection to accelerate the deployment of its insomnia treatment platform. The strategic roadmap likely includes expanding clinical partnerships, enhancing the digital user experience, and scaling operations to meet the needs of a broader patient demographic. By focusing on long-term clinical outcomes and cost-efficiency, the company is set to establish itself as a leader in the digital sleep medicine space. Continued investment will be critical as the firm navigates the complexities of healthcare integration and seeks to prove the long-term viability of its scalable care model.
See full Dawn company page
